Aldeyra Therapeutics Statistics

Total Valuation

ALDX has a market cap or net worth of $398.26 million. The enterprise value is $312.41 million.

Market Cap	398.26M
Enterprise Value	312.41M

Important Dates

The next estimated earnings date is Thursday, May 1, 2025, after market close.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

ALDX has 59.71 million shares outstanding. The number of shares has increased by 0.92% in one year.

Current Share Class	59.71M
Shares Outstanding	59.71M
Shares Change (YoY)	+0.92%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	2.58%
Owned by Institutions (%)	39.14%
Float	43.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.60
P/TBV Ratio	5.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.59, with a Debt / Equity ratio of 0.22.

Current Ratio	5.59
Quick Ratio	5.44
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-31.21

Financial Efficiency

Return on equity (ROE) is -58.54% and return on invested capital (ROIC) is -33.89%.

Return on Equity (ROE)	-58.54%
Return on Assets (ROA)	-29.71%
Return on Invested Capital (ROIC)	-33.89%
Return on Capital Employed (ROCE)	-69.90%
Revenue Per Employee	n/a
Profits Per Employee	-$6.21M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +116.56% in the last 52 weeks. The beta is 1.23, so ALDX's price volatility has been higher than the market average.

Beta (5Y)	1.23
52-Week Price Change	+116.56%
50-Day Moving Average	6.07
200-Day Moving Average	5.14
Relative Strength Index (RSI)	54.67
Average Volume (20 Days)	767,702

Short Selling Information

The latest short interest is 3.68 million, so 6.16% of the outstanding shares have been sold short.

Short Interest	3.68M
Short Previous Month	3.67M
Short % of Shares Out	6.16%
Short % of Float	8.47%
Short Ratio (days to cover)	6.27

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-60.12M
Pretax Income	n/a
Net Income	-55.85M
EBITDA	-59.87M
EBIT	-60.12M
Earnings Per Share (EPS)	-$0.94

Full Income Statement

Balance Sheet

The company has $101.15 million in cash and $15.30 million in debt, giving a net cash position of $85.85 million or $1.44 per share.

Cash & Cash Equivalents	101.15M
Total Debt	15.30M
Net Cash	85.85M
Net Cash Per Share	$1.44
Equity (Book Value)	71.00M
Book Value Per Share	1.19
Working Capital	85.47M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-43.21M
Capital Expenditures	n/a
Free Cash Flow	-43.21M
FCF Per Share	-$0.72

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.92%
Shareholder Yield	-0.92%
Earnings Yield	-14.02%
FCF Yield	-10.85%

Analyst Forecast

The average price target for ALDX is $10.00, which is 49.93% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	49.93%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1